Breakthrough FDA approval for first solid tumor cell therapy signals new era for cancer treatment
Exciting advancements are on the horizon for cancer treatment. Earlier this year, the FDA approved Lifileucel, an autologous tumor infiltrating lymphocyte (TIL) product for the treatment of melanoma. A recent article published in Drug Discovery and Development by Cartherics’ Prof. Alan Trounson and Dr. Ian Nisbet discusses how this approval marks a significant milestone in […]